Literature DB >> 32741481

Update on the Genetics of Pituitary Tumors.

Sayka Barry1, Márta Korbonits2.   

Abstract

Pituitary adenomas are common intracranial neoplasms, with diverse phenotypes. Most of these tumors occur sporadically and are not part of genetic disorders. Over the last decades numerous genetic studies have led to identification of somatic and germline mutations associated with pituitary tumors, which has advanced the understanding of pituitary tumorigenesis. Exploring the genetic background of pituitary neuroendocrine tumors can lead to early diagnosis associated with better outcomes, and their molecular mechanisms should lead to novel targeted therapies even for sporadic tumors. This article summarizes the genes and the syndromes associated with pituitary tumors.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AIP; Acromegaly; FIPA; Genetic testing; MEN1; Pituitary adenomas; Prolactinoma

Mesh:

Year:  2020        PMID: 32741481     DOI: 10.1016/j.ecl.2020.05.005

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  9 in total

Review 1.  Hypothalamic syndrome.

Authors:  Hermann L Müller; Maithé Tauber; Elizabeth A Lawson; Jale Özyurt; Brigitte Bison; Juan-Pedro Martinez-Barbera; Stephanie Puget; Thomas E Merchant; Hanneke M van Santen
Journal:  Nat Rev Dis Primers       Date:  2022-04-21       Impact factor: 52.329

2.  Alternative Lengthening of Telomeres (ALT) and Telomerase Reverse Transcriptase Promoter Methylation in Recurrent Adult and Primary Pediatric Pituitary Neuroendocrine Tumors.

Authors:  Hiba Alzoubi; Simone Minasi; Francesca Gianno; Manila Antonelli; Francesca Belardinilli; Felice Giangaspero; Marie-Lise Jaffrain-Rea; Francesca Romana Buttarelli
Journal:  Endocr Pathol       Date:  2022-01-06       Impact factor: 3.943

Review 3.  Aggressive prolactinoma (Review).

Authors:  Ana Valea; Florica Sandru; Aida Petca; Mihai Cristian Dumitrascu; Mara Carsote; Razvan-Cosmin Petca; Adina Ghemigian
Journal:  Exp Ther Med       Date:  2021-11-24       Impact factor: 2.447

4.  Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma.

Authors:  Meng Wang; Chenxing Ji; Yichao Zhang; Zhiqiang Zhang; Yu Zhang; Huiping Guo; Nidan Qiao; Xiang Zhou; Xiaoyun Cao; Zhen Ye; Yifei Yu; Vladimir Melnikov; Wei Gong; Min He; Zhaoyun Zhang; Yao Zhao; Xuelong Wang; Gang Wei; Zhao Ye
Journal:  Endocrine       Date:  2022-08-10       Impact factor: 3.925

5.  Natriuretic Peptide Expression and Function in GH3 Somatolactotropes and Feline Somatotrope Pituitary Tumours.

Authors:  Samantha M Mirczuk; Christopher J Scudder; Jordan E Read; Victoria J Crossley; Jacob T Regan; Karen M Richardson; Bigboy Simbi; Craig A McArdle; David B Church; Joseph Fenn; Patrick J Kenny; Holger A Volk; Caroline P Wheeler-Jones; Márta Korbonits; Stijn J Niessen; Imelda M McGonnell; Robert C Fowkes
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

Review 6.  Familial Hyperparathyroidism.

Authors:  Jenny E Blau; William F Simonds
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

Review 7.  The clinical aspects of pituitary tumour genetics.

Authors:  Judit Dénes; Márta Korbonits
Journal:  Endocrine       Date:  2021-02-04       Impact factor: 3.633

Review 8.  Treatment of Prolactinoma.

Authors:  Warrick J Inder; Christina Jang
Journal:  Medicina (Kaunas)       Date:  2022-08-13       Impact factor: 2.948

Review 9.  Genetics of Acromegaly and Gigantism.

Authors:  Anna Bogusławska; Márta Korbonits
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.